Stocktoria

PhenixFIN Corp PFXNZ

Nasdaq · XNAS · stock
Chart by TradingView
2/9
Piotroski F — financial health
Altman Z″ — distress risk
69.5%
Dividend payout · stretched

Financials (annual, from 10-K)

FYRevenueNet incomeGross profitFree cash flowEquity
2025$4.2M$160.8M
2024$18.6M$160.3M
2023$26.9M$146.7M
2022-$6.1M$120.8M

Recent insider activity (Form 4)

InsiderRoleDateActionSharesPrice
Lorber David ACHAIRMAN AND CEO2026-06-03Buy3,183$45.49
Lorber David ACHAIRMAN AND CEO2026-06-03Buy800$44.40
Lorber David ACHAIRMAN AND CEO2026-06-02Buy2,473$44.95
Lorber David ACHAIRMAN AND CEO2026-06-01Buy1$41.20
Lorber David ACHAIRMAN AND CEO2026-06-01Buy1,363$44.37
Lorber David ACHAIRMAN AND CEO2026-06-01Buy836$44.99
Lorber David ACHAIRMAN AND CEO2026-05-12Buy42,065$39.95
Amster Howarddirector2026-03-03Buy11,500$42.56

Why these scores methodology →

Piotroski F-score: 2/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: n/a

Not applicable (financials/insurer or missing inputs).

Source: SEC EDGAR filings · CIK 0001490349 · as of 2025-09-30. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.